Revisión actualizada de los beneficios de la Citicolina como neuroprotector en el post evento cerebro vascular

Edgar Santiago  Castro Freire; Andrea Aracely  Cedeño Patiño; Steban Xavier  Cedeño Párraga; Luis Clemente  García Zambrano; Mauro Enrique  García Muguerza; Jhon Alexander  Ponce Alencastro

doi:10.59282/reincisol.V3(6)207-307

Authors

Edgar Santiago Castro Freire Universidad Técnica de Manabí https://orcid.org/0009-0001-4970-7555
Andrea Aracely Cedeño Patiño Universidad Técnica de Manabí https://orcid.org/0009-0009-5222-0754
Steban Xavier Cedeño Párraga Universidad Técnica de Manabí https://orcid.org/0009-0003-0425-2774
Luis Clemente García Zambrano Universidad Técnica de Manabí https://orcid.org/0009-0000-0252-1385
Mauro Enrique García Muguerza Universidad Técnica de Manabí https://orcid.org/0009-0001-1560-7994
Jhon Alexander Ponce Alencastro Universidad Técnica de Manabí https://orcid.org/0000-0002-3666-7865

DOI:

https://doi.org/10.59282/reincisol.V3(6)207-307

Keywords:

stroke, citicoline, benefits, neuroprotective.

Abstract

A considerable cause of physical and cognitive disability is stroke. To prevent damage or reduce the appearance of lesions after a cerebrovascular event at the level of the central nervous system, neuroprotective drugs such as citicoline are used. Neuroprotective agents are important in the prevention of neurodegenerative diseases and in the protection of traumatic injuries. Describe the benefits of citicoline as a neuroprotector in the post-cerebrovascular event. Documentary descriptive type research. The DeCS/MeSH descriptors provided us with the keywords “benefit”, “neuroprotective”, “cerebrovascular accident” and “Citicoline” for subsequent collection, review and analysis of bibliographic sources in databases such as PubMed, Elsevier and Scopus, in Spanish and English, through the Google Academic search engine and the Boolean operators AND, OR and NOT, related to the topic raised. The studies reviewed show evidence that patients with acute stroke can benefit from treatment with citicoline by obtaining better functional and neurological recovery, in addition to being a safe and useful drug. In conclusion, citicoline is highly safe and induces neuronal regeneration. In this way, it represents a viable pharmacological option for patients who have suffered an ischemic stroke.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

References

Agarwal, A., Vishnu, V. Y., Sharma, J., Bhatia, R., Garg, A., Dwivedi, S., Upadhyay, A., Goyal, V., Singh, M. B., Gupta, A., Rajan, R., & Padma Srivastava, M. V. (2022a). Citicoline in acute ischemic stroke: A randomized controlled trial. PLoS ONE, 17(5 May). https://doi.org/10.1371/journal.pone.0269224

Agarwal, A., Vishnu, V. Y., Sharma, J., Bhatia, R., Garg, A., Dwivedi, S., Upadhyay, A., Goyal, V., Singh, M. B., Gupta, A., Rajan, R., & Padma Srivastava, M. V. (2022b). Citicoline in acute ischemic stroke: A randomized controlled trial. PLOS ONE, 17(5), e0269224. https://doi.org/10.1371/JOURNAL.PONE.0269224

Agarwal, A., Vishnu, V. Y., Sharma, J., Bhatia, R., Garg, A., Dwivedi, S., Upadhyay, A., Goyal, V., Singh, M. B., Gupta, A., Rajan, R., & Padma Srivastava, M. V. (2022c). Citicoline in acute ischemic stroke: A randomized controlled trial. PLoS ONE, 17(5). https://doi.org/10.1371/JOURNAL.PONE.0269224

Almeria, M., Alvarez, I., Molina-Seguin, J., Besora, S., Buongiorno, M., Romero, S., Casas, L., Cano, C., Castejon, J., Arribas, S., & Krupinski, J. (2023). Citicoline May Prevent Cognitive Decline in Patients with Cerebrovascular Disease. Clinical Interventions in Aging, 18, 1093. https://doi.org/10.2147/CIA.S409994

Arcadi, F. A., Corallo, F., Torrisi, M., Scarfì, C., Lo Buono, V., Formica, C., Bramanti, P., Marino, S., Bonanno, L., & De Cola, M. C. (2021). Role of citicoline and choline in the treatment of post-stroke depression: an exploratory study. The Journal of International Medical Research, 49(11), 1–7. https://doi.org/10.1177/03000605211055036

Barthels, D., & Das, H. (2020a). Current Advances in Ischemic Stroke Research and Therapies. Biochimica et Biophysica Acta. Molecular Basis of Disease, 1866(4), 165260. https://doi.org/10.1016/J.BBADIS.2018.09.012

Barthels, D., & Das, H. (2020b). Current Advances in Ischemic Stroke Research and Therapies. Biochimica et Biophysica Acta. Molecular Basis of Disease, 1866(4), 165260. https://doi.org/10.1016/J.BBADIS.2018.09.012

Cakir, A., Ocalan, B., Koc, C., Suyen, G. G., Cansev, M., & Kahveci, N. (2022). Effects of citicoline administration on synaptic proteins in rapid eye movement sleep-deprived rats. Iranian Journal of Basic Medical Sciences, 25(5), 562–568. https://doi.org/10.22038/IJBMS.2022.60756.13462

Ciarambino, T., Crispino, P., Mastrolorenzo, E., Viceconti, A., & Giordano, M. (2022). Stroke and Etiopathogenesis: What Is Known? In Genes (Vol. 13, Issue 6). MDPI. https://doi.org/10.3390/genes13060978

Corallo, F., Scarfì, C., Arcadi, F. A., Formica, C., Di Cara, M., Palmeri, R., Romeo, L., Lo Buono, V., Bramanti, P., Marino, S., & De Cola, M. C. (2020). Role of functional pharmacological therapy in post-stroke depression: a narrative review. The Journal of International Medical Research, 48(10). https://doi.org/10.1177/0300060520950557

Gandolfi, S., Marchini, G., Caporossi, A., Scuderi, G., Tomasso, L., & Brunoro, A. (2020). Cytidine 5′-Diphosphocholine (Citicoline): Evidence for a Neuroprotective Role in Glaucoma. Nutrients, 12(3). https://doi.org/10.3390/NU12030793

Goel, D., Shangari, S., Mittal, M., & Bhat, A. (2024). Endogenous defense mechanism-based neuroprotection in large-vessel acute ischemic stroke: A hope for future. Brain Circulation, 10(1), 51. https://doi.org/10.4103/BC.BC_56_23